| Name | Title | Contact Details |
|---|
BioBlast Pharma is a clinical-stage biotechnology company committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. The Company is building a diverse portfolio of product candidates with the potential to address unmet medical needs for incurable diseases. The BioBlast platforms are based on deep understandings of the disease-causing biological processes, and potentially offer solutions for several diseases that share the same biological pathology.
Avecia Biotechnology is a Milford, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Degraft-Johnson and Associates is a Chadds Ford, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Aeras is constantly producing new constructs that will also be made available following phenotypic, genotypic and stability characterization. Aeras is also glad to provide shigella carrier strains with capsids expressing TB antigens under similar
J&S Studies, Inc. is a Bryan, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.